Quipt Home Medical Corp. (QIPT)
USD 2.2
(-2.22%)
USD 2.2
(-2.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.91 Million USD | -13.06% |
| 2022 | 17.35 Million USD | 497.45% |
| 2021 | 2.9 Million USD | -35.31% |
| 2020 | 4.49 Million CAD | 58.74% |
| 2019 | 2.82 Million CAD | 2655.99% |
| 2018 | -110.68 Thousand CAD | 99.14% |
| 2017 | -12.89 Million CAD | 68.25% |
| 2016 | -40.6 Million CAD | -663.04% |
| 2015 | 7.21 Million CAD | 167.82% |
| 2014 | 2.69 Million CAD | 807.14% |
| 2013 | 296.86 Thousand CAD | 154.13% |
| 2012 | -548.4 Thousand CAD | -286.51% |
| 2011 | 294.02 Thousand CAD | 117.39% |
| 2010 | -1.69 Million CAD | -107.04% |
| 2009 | -816.81 Thousand CAD | -64.37% |
| 2008 | -496.93 Thousand CAD | -1738.85% |
| 2007 | 30.32 Thousand CAD | 115.06% |
| 2006 | -201.33 Thousand CAD | 39.55% |
| 2005 | -333.05 Thousand CAD | 8.87% |
| 2004 | -365.49 Thousand CAD | -287.38% |
| 2003 | -94.34 Thousand CAD | 22.5% |
| 2002 | -121.73 Thousand CAD | 64.61% |
| 2001 | -344.02 Thousand CAD | -420.79% |
| 2000 | -66.05 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.2 Million USD | -13.6% |
| 2024 Q3 | 1.08 Million USD | -67.17% |
| 2024 Q1 | 1.59 Million USD | -65.62% |
| 2023 FY | 15.08 Million USD | -13.06% |
| 2023 Q3 | 170 Thousand USD | -97.88% |
| 2023 Q4 | 3.99 Million USD | 2252.35% |
| 2023 Q2 | 8 Million USD | 104.47% |
| 2023 Q1 | 3.91 Million USD | -8.53% |
| 2022 Q4 | 4.27 Million USD | -1.63% |
| 2022 Q1 | -1.18 Million USD | 63.08% |
| 2022 FY | 17.35 Million USD | 497.45% |
| 2022 Q2 | 4.44 Million USD | 476.61% |
| 2022 Q3 | 4.35 Million USD | -2.12% |
| 2021 FY | 2.9 Million USD | -35.31% |
| 2021 Q2 | 1.41 Million USD | -63.46% |
| 2021 Q3 | -1.11 Million USD | -178.49% |
| 2021 Q4 | -3.19 Million USD | -187.15% |
| 2021 Q1 | 3.88 Million USD | 1732.61% |
| 2020 Q4 | -237.71 Thousand CAD | -214.73% |
| 2020 FY | 4.49 Million CAD | 58.74% |
| 2020 Q2 | 120.57 Thousand CAD | 137.59% |
| 2020 Q1 | -320.76 Thousand CAD | -121.14% |
| 2020 Q3 | 207.2 Thousand CAD | 71.85% |
| 2019 Q1 | 1.28 Million CAD | 108.42% |
| 2019 Q2 | 1.33 Million CAD | 4.4% |
| 2019 FY | 2.82 Million CAD | 2655.99% |
| 2019 Q3 | -906.45 Thousand CAD | -167.73% |
| 2019 Q4 | 1.51 Million CAD | 267.38% |
| 2018 Q3 | 248.17 Thousand CAD | 143.31% |
| 2018 Q4 | -15.23 Million CAD | -6237.08% |
| 2018 FY | -110.68 Thousand CAD | 99.14% |
| 2018 Q1 | -3.16 Million CAD | 59.57% |
| 2018 Q2 | -573 Thousand CAD | 81.88% |
| 2017 Q4 | -7.82 Million CAD | -182.15% |
| 2017 Q1 | -3.2 Million CAD | 79.28% |
| 2017 Q3 | -2.77 Million CAD | -404.39% |
| 2017 FY | -12.89 Million CAD | 68.25% |
| 2017 Q2 | 911 Thousand CAD | 128.4% |
| 2016 Q3 | -9.91 Million CAD | 39.6% |
| 2016 Q1 | -1.75 Million CAD | -122.41% |
| 2016 FY | -40.6 Million CAD | -663.04% |
| 2016 Q4 | -15.48 Million CAD | -56.14% |
| 2016 Q2 | -16.41 Million CAD | -837.45% |
| 2015 FY | 7.21 Million CAD | 167.82% |
| 2015 Q2 | 1.49 Million CAD | 10.12% |
| 2015 Q4 | 7.81 Million CAD | 424.6% |
| 2015 Q3 | 1.48 Million CAD | -0.13% |
| 2015 Q1 | 1.35 Million CAD | 182.15% |
| 2014 Q4 | -1.64 Million CAD | -436.49% |
| 2014 FY | 2.69 Million CAD | 807.14% |
| 2014 Q3 | 490.01 Thousand CAD | 58.19% |
| 2014 Q1 | 11.38 Thousand CAD | -84.43% |
| 2014 Q2 | 309.76 Thousand CAD | 2620.37% |
| 2013 Q2 | 74.91 Thousand CAD | -22.73% |
| 2013 Q4 | 73.14 Thousand CAD | 39.71% |
| 2013 FY | 296.86 Thousand CAD | 154.13% |
| 2013 Q3 | 52.35 Thousand CAD | -30.11% |
| 2013 Q1 | 96.95 Thousand CAD | 218.46% |
| 2012 Q2 | 345.66 Thousand CAD | -16.15% |
| 2012 Q4 | -81.84 Thousand CAD | 28.16% |
| 2012 Q3 | -113.93 Thousand CAD | -132.96% |
| 2012 FY | -548.4 Thousand CAD | -286.51% |
| 2012 Q1 | 412.22 Thousand CAD | 37.3% |
| 2011 Q3 | 92.35 Thousand CAD | 2110.28% |
| 2011 FY | 294.02 Thousand CAD | 117.39% |
| 2011 Q1 | -90.98 Thousand CAD | 89.52% |
| 2011 Q2 | -4594.05 CAD | 94.95% |
| 2011 Q4 | 300.24 Thousand CAD | 225.1% |
| 2010 Q4 | -868.46 Thousand CAD | -19.36% |
| 2010 Q1 | -95.8 Thousand CAD | -111.41% |
| 2010 Q2 | -80.1 Thousand CAD | 16.39% |
| 2010 FY | -1.69 Million CAD | -107.04% |
| 2010 Q3 | -727.63 Thousand CAD | -808.37% |
| 2009 FY | -816.81 Thousand CAD | -64.37% |
| 2009 Q4 | -45.31 Thousand CAD | -1162.75% |
| 2009 Q3 | 4264.20 CAD | 106.63% |
| 2009 Q2 | -64.27 Thousand CAD | -8.33% |
| 2009 Q1 | -59.33 Thousand CAD | 53.73% |
| 2008 Q3 | -271.3 Thousand CAD | -143.7% |
| 2008 Q2 | -111.32 Thousand CAD | -14.82% |
| 2008 Q1 | -96.96 Thousand CAD | -115.72% |
| 2008 FY | -496.93 Thousand CAD | -1738.85% |
| 2008 Q4 | -128.22 Thousand CAD | 52.74% |
| 2007 FY | 30.32 Thousand CAD | 115.06% |
| 2007 Q4 | 616.82 Thousand CAD | 1699.1% |
| 2007 Q3 | -38.57 Thousand CAD | -283.72% |
| 2007 Q2 | 20.99 Thousand CAD | -61.62% |
| 2007 Q1 | 54.7 Thousand CAD | -89.2% |
| 2006 FY | -201.33 Thousand CAD | 39.55% |
| 2006 Q2 | 28.91 Thousand CAD | 114.33% |
| 2006 Q1 | -201.76 Thousand CAD | -572.34% |
| 2006 Q3 | -41.63 Thousand CAD | -244.01% |
| 2006 Q4 | 506.7 Thousand CAD | 1317.06% |
| 2005 FY | -333.05 Thousand CAD | 8.87% |
| 2005 Q1 | -170.98 Thousand CAD | -3.7% |
| 2005 Q2 | -81.87 Thousand CAD | 52.12% |
| 2005 Q3 | 90.63 Thousand CAD | 210.7% |
| 2005 Q4 | -30 Thousand CAD | -133.11% |
| 2004 Q2 | -169.66 Thousand CAD | -513.23% |
| 2004 Q3 | -169.76 Thousand CAD | -0.06% |
| 2004 Q4 | -164.87 Thousand CAD | 2.87% |
| 2004 FY | -365.49 Thousand CAD | -287.38% |
| 2004 Q1 | 41.05 Thousand CAD | 163.51% |
| 2003 Q1 | -9428.89 CAD | -3901.1% |
| 2003 FY | -94.34 Thousand CAD | 22.5% |
| 2003 Q4 | -64.65 Thousand CAD | -138.79% |
| 2003 Q3 | 166.66 Thousand CAD | 657.36% |
| 2003 Q2 | 22 Thousand CAD | 333.39% |
| 2002 Q1 | -35.76 Thousand CAD | 32.0% |
| 2002 FY | -121.73 Thousand CAD | 64.61% |
| 2002 Q3 | -70.41 Thousand CAD | -445.03% |
| 2002 Q4 | -235.66 CAD | 99.67% |
| 2002 Q2 | 20.4 Thousand CAD | 157.06% |
| 2001 Q4 | -52.59 Thousand CAD | 0.0% |
| 2001 FY | -344.02 Thousand CAD | -420.79% |
| 2000 FY | -66.05 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 127.289% |
| Cerus Corporation | -30.05 Million USD | 113.04% |
| OrthoPediatrics Corp. | -25.76 Million USD | 115.21% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 136.897% |
| Talis Biomedical Corporation | -66.81 Million USD | 105.865% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 122.658% |
| Inogen, Inc. | -109.38 Million USD | 103.583% |
| Spectral AI, Inc. | -12.98 Million USD | 130.183% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 106.261% |
| CVRx, Inc. | -43.1 Million USD | 109.092% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 211.083% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 131.534% |
| Orthofix Medical Inc. | -139.11 Million USD | 102.817% |
| Venus Concept Inc. | -28.3 Million USD | 113.844% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 107.254% |
| Bioventus Inc. | -81.72 Million USD | 104.795% |
| BrainsWay Ltd. | -4.92 Million USD | 179.541% |
| Envoy Medical, Inc. | -18.37 Million USD | 121.333% |
| electroCore, Inc. | -18.8 Million USD | 120.84% |
| IceCure Medical Ltd | -15.57 Million USD | 125.161% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 108.083% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 122.695% |
| MaxCyte, Inc. | -48.29 Million USD | 108.114% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 132.781% |
| Nexalin Technology, Inc. | -5.69 Million USD | 168.799% |
| PAVmed Inc | -68.79 Million USD | 105.697% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 106.929% |
| RxSight, Inc. | -50.08 Million USD | 107.825% |
| Sight Sciences, Inc. | -57.27 Million USD | 106.843% |
| SI-BONE, Inc. | -46.93 Million USD | 108.351% |
| TELA Bio, Inc. | -44.07 Million USD | 108.892% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 107.237% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 107.62% |
| LivaNova PLC | -68.49 Million USD | 105.721% |
| 908 Devices Inc. | -42.75 Million USD | 109.166% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 102.26% |
| Nemaura Medical Inc. | -9.59 Million USD | 140.843% |
| NeuroPace, Inc. | -27.17 Million USD | 114.422% |
| LENSAR, Inc. | -12.22 Million USD | 132.047% |
| Apyx Medical Corporation | -17.25 Million USD | 122.707% |
| Cutera, Inc. | -156.23 Million USD | 102.508% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 145.549% |
| BioSig Technologies, Inc. | -28.51 Million USD | 113.745% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 104.472% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 117.46% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 96.486% |
| Axonics, Inc. | -26.05 Million USD | 115.04% |
| Outset Medical, Inc. | -169.77 Million USD | 102.308% |
| IRIDEX Corporation | -10 Million USD | 139.163% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 103.59% |
| IRadimed Corporation | 20.03 Million USD | 80.44% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 147.532% |
| INVO Bioscience, Inc. | -6.76 Million USD | 157.912% |
| Telesis Bio, Inc. | -35.15 Million USD | 111.149% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 72.652% |
| Varex Imaging Corporation | 32.1 Million USD | 87.791% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 132.3% |
| Pulmonx Corporation | -61.93 Million USD | 106.328% |
| Dynatronics Corporation | -2.27 Million USD | 272.412% |
| Modular Medical, Inc. | -17.52 Million USD | 122.357% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 126.771% |
| Semler Scientific, Inc. | 22.25 Million USD | 82.391% |
| InMode Ltd. | 195.66 Million USD | 97.997% |
| Bruker Corporation | 436.9 Million USD | 99.103% |
| Cytosorbents Corporation | -31.2 Million USD | 112.557% |
| DexCom, Inc. | 597.7 Million USD | 99.344% |
| Align Technology, Inc. | 643.33 Million USD | 99.391% |
| Viveve Medical, Inc. | -21.55 Million USD | 118.183% |
| ZimVie Inc. | -30.93 Million USD | 112.667% |
| Movano Inc. | -29.69 Million USD | 113.2% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 114.074% |
| Nexalin Technology, Inc. | -5.69 Million USD | 168.799% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 211.083% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 101.68% |
| Profound Medical Corp. | -28.61 Million USD | 113.695% |
| Insulet Corporation | 220 Million USD | 98.219% |
| enVVeno Medical Corporation | -25.23 Million USD | 115.528% |
| Surmodics, Inc. | -5.64 Million USD | 169.424% |
| iCAD, Inc. | -7.68 Million USD | 150.969% |
| Nuwellis, Inc. | -17.63 Million USD | 122.229% |
| Biotricity, Inc. | -8.82 Million USD | 144.391% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 103.131% |
| Aethlon Medical, Inc. | -12.63 Million USD | 131.013% |
| InspireMD, Inc. | -21.14 Million USD | 118.536% |
| PAVmed Inc. | -68.79 Million USD | 105.697% |
| BIOLASE, Inc. | -17.93 Million USD | 121.849% |
| Beyond Air, Inc. | -63 Million USD | 106.22% |
| FONAR Corporation | 16.53 Million USD | 76.299% |
| AxoGen, Inc. | -21.46 Million USD | 118.26% |
| Vivani Medical, Inc. | -26.96 Million USD | 114.534% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 78.277% |
| Inari Medical, Inc. | -14.03 Million USD | 127.929% |
| UFP Technologies, Inc. | 57.66 Million USD | 93.204% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 179.532% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 162.149% |
| Tenon Medical, Inc. | -15.72 Million USD | 124.919% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 152.435% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 109.177% |
| AdaptHealth Corp. | -598.4 Million USD | 100.655% |
| Sintx Technologies, Inc. | -13.35 Million USD | 129.338% |
| NanoVibronix, Inc. | -3.43 Million USD | 214.057% |
| Quanterix Corporation | -49.7 Million USD | 107.885% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 132.3% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 1125.916% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 101.172% |
| TransMedics Group, Inc. | -28.72 Million USD | 113.642% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 116.597% |
| NeuroMetrix, Inc. | -7.15 Million USD | 154.8% |
| Hyperfine, Inc. | -48.11 Million USD | 108.145% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 106.027% |
| Biomerica, Inc. | -6.36 Million USD | 161.552% |
| Bone Biologics Corporation | -9.42 Million USD | 141.566% |
| AVITA Medical, Inc. | -40.4 Million USD | 109.7% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 138.007% |
| Silk Road Medical, Inc | -59.27 Million USD | 106.612% |